Hepatic hemangiomas are benign tumors that develop in the liver and may not cause any symptoms. These tumors are formed from a collection of extra blood vessels, and are the most common type of benign liver tumor. They can range in size from a few millimeters to several centimeters, and are typically located near the surface of the liver. Hepatic hemangiomas can be detected through imaging tests such as ultrasound, CT scans, and MRI scans. If the tumor is large enough, it may be visible on abdominal X-rays. In some cases, a biopsy may be necessary to confirm the diagnosis. Most hepatic hemangiomas do not require treatment and may shrink over time on their own. However, if the tumor is causing pain or discomfort, surgery may be an option to remove it. Some medications such as corticosteroids or interferon can also be used to shrink the tumor or reduce its symptoms. In rare cases, hepatic hemangiomas can become cancerous. This is why it is important to have regular check-ups with your doctor to monitor the size and growth of the tumor. If there are any changes in size or appearance of the tumor, it should be evaluated promptly. Hepatic hemangiomas are generally not dangerous and do not cause any long-term health problems. However, they should still be monitored closely by your doctor so that any changes can be detected early and appropriate treatment can be started if necessary.
Title : Gastroenterology viewed through a glass darkly an IDI perspective
Gilles R G Monif, University of Florida and Infectious Diseases Incorporated, United States
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena Hospital, Italy
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States